Organigram Holdings (TSX.V: OGI) (NASDAQ: OGI), a leading
licensed producer of cannabis and extract-based products, today announced that
it was selected as one of the four Canadian launch partners of PAX Era, the
premium oil vaporizer created by PAX Labs, Inc. PAX Labs is a leading consumer
technology brand in the design and development of premium vaporizers for dry
flower, as well as concentrates when they become legal in Canada later this
year. “Cannabis 2.0 – the next generation of legal, adult use cannabis products
– represents a world of opportunity,” Organigram CEO Greg Engel said in the
news release. “Innovative partnerships with exceptional companies like PAX mean
our own product offering grows and our customers have access to cutting-edge
technology and cannabis experiences.”
To view the full press release, visit http://ibn.fm/Bo6az
About Organigram Holdings Inc.
Organigram Holdings Inc. is a TSX Venture Exchange listed
company whose wholly owned subsidiary, Organigram Inc., is a licensed producer
of cannabis and cannabis-derived products in Canada. Organigram is focused on producing
the highest-quality, indoor-grown cannabis for patients and adult recreational
consumers in Canada, as well as developing international business partnerships
to extend the company’s global footprint. Organigram has also developed a
portfolio of legal adult use recreational cannabis brands including The Edison
Cannabis Company, Ankr Organics, Trailer Park Buds and Trailblazer.
Organigram’s primary facility is located in Moncton, New Brunswick and the
Company is regulated by the Cannabis Act and the Cannabis Regulations (Canada).
For more information, visit the company’s website at www.Organigram.ca.
NOTE TO INVESTORS: The latest news and updates
relating to OGRMF are available in the company’s newsroom at http://ibn.fm/OGRMF
About MissionIRNewsBreaks
MissionIRNewsBreaks provide
a rapid summary of corporate news that catch the attention of MissionIR. MissionIRNewsBreaks are created by
our Team of professional journalists that keep a constant eye on the markets,
these posts are designed to inform you on the latest happenings of our clients
and other publicly traded companies on our radar. From earnings, acquisitions
and agreements to conference attendance and clinical study results, our news
breaks keep you up-to-date with the day’s top movers. MissionIR is primarily
focused on strategic communications. We have executed countless communications
programs to address the needs of companies ranging from start-ups to
established industry leaders, gaining valuable experience and the expertise
necessary to determine the most effective strategy for any given situation.
Please see full terms of use and disclaimers on the Mission
Investor Relations website applicable to all content provided by MIR, wherever
published or re-published: http://www.missionir.com/disclaimer.html
